'Pharma bro' Martin Shkreli's company files for bankruptcy
KaloBios Pharmaceuticals filed for Chapter 11 bankruptcy on Tuesday, only shortly after firing their notorious "pharma bro" CEO Martin Shkreli. The company listed both its assets and liabilities in the range of $1 million to $10 million, Reuters reports.
Shkreli, who was also the CEO of Turing Pharmaceuticals, was fired from KaloBios and resigned from Turing following allegations of securities fraud and conspiracy. Shkreli earned notoriety earlier this year after hiking the price of a life-saving AIDS and cancer drug from $13.50 to $750.